CACNA1C p.Pro44Ala
c.130C>G · rs1057518456 · VCV373514
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.327 | indeterminate |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2, phastCons 1 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 62 kb · p 0.13 · regional, not allelic |
| Overall | ||
| CADD | 24.0 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CACNA1C
- Protein
- p.Pro44Ala
- Coding
- c.130C>G
- MANE Select
- NM_000719
- dbSNP
- rs1057518456
- Type
- single nucleotide variant
- Location
- chr12:2115304 (GRCh38)
- Gene constraint
- LOEUF 0.186 · pLI 1.00 · ClinGen HI 1/3 (gnomAD)
- Structure
- AlphaFold pLDDT 62.73 · 33 PDB
Disease context
Brugada syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: long QT syndrome
For Brugada syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- CACNA1C p.Pro44= Likely benign ★★ same residue
- CACNA1C p.Arg518Cys Pathogenic/Likely pathogenic ★★ same condition
- CACNA1C p.Arg518His Pathogenic/Likely pathogenic ★★ same condition
- CACNA1C p.Arg858His Pathogenic/Likely pathogenic ★★ same condition
- CACNA1C p.Arg860Gly Likely pathogenic ★★ same condition
- CACNA1C p.Arg860Ter Pathogenic ★★ same condition
- CACNA1C p.Glu1115Lys Pathogenic/Likely pathogenic ★★ same condition
- CACNA1C p.Gly1378Arg Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cacna1c-p-pro44ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown